References
  1. Abdelnabi M, Elmssary M, Sekhon J, Benjanuwattra J. Acute onset of fever, eosinophilia, rash, acute kidney injury, and a positive Monospot test in a patient on lamotrigine: DRESS syndrome. The Lancet . 2022;399(10338):1902. DOI: 10.1016/S0140-6736(22)00464-0
  2. Sasidharanpillai S, Riyaz N, Khader A, Rajan U, Binitha MP, Sureshan DN. Severe cutaneous adverse drug reactions: a clinicoepidemiological study. Indian J Dermatol . 2015;60(1):102. DOI: 10.4103/0019-5154.147834
  3. De A, Rajagopalan M, Sarda A, Das S, Biswas P. Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature. Indian J Dermatol . 2018;63(1):30-40. DOI: 10.4103/ijd.IJD_582_17
  4. Choudhary S, McLeod M, Torchia D, Romanelli P. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. J Clin Aesthet Dermatol . 2013;6(6):31-37.
  5. Nanishi E, Hoshina T, Ohga S, Nishio H, Hara T. Drug reaction with eosinophilia and systemic symptoms during primary Epstein-Barr virus infection. J Microbiol Immunol Infect . 2015;48(1):109-112. DOI: 10.1016/j.jmii.2014.06.012.
  6. Benjanuwattra J, Cavasos A, Abdelnabi M. DRESS syndrome–Authors’ reply. The Lancet . 2022;400(10352):560-1. DOI: 10.1016/S0140-6736(22)01386-1.
  7. Roujeau JC, Dupin N. Virus Reactivation in Drug Reaction with Eosinophilia and Systemic Symptoms (Dress) Results from a Strong Drug-Specific Immune Response. J Allergy Clin Immunol Pract . 2017;5(3):811-812. DOI: 10.1016/j.jaip.2016.11.027.
  8. Qadri I, Zeng X, Guo R, Koratala A. Acute interstitial nephritis and DRESS syndrome without eosinophilia associated with cefepime.BMJ Case Rep . 2017;2017. DOI: 10.1136/bcr-2017-221401